KATHLEEN CAMPBELL: Open Payments
NPI 1649385857 · SCHENECTADY, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,223 in 59 payments from 17 companies in 2025. Trend: 2023 $944 · 2024 $579 · 2025 $1,223
Food & beverage: $1,223
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 13 | $265 |
| GlaxoSmithKline, LLC. | 9 | $252 |
| ABBVIE INC. | 11 | $179 |
| Abbott Laboratories | 6 | $122 |
| Lilly USA, LLC | 3 | $87 |
| Viatris Specialty LLC | 2 | $39 |
| Merck Sharp & Dohme LLC | 2 | $38 |
| Exact Sciences Corporation | 2 | $35 |
| Amgen Inc. | 2 | $31 |
| SANOFI-AVENTIS U.S. LLC | 1 | $29 |
Products named: AREXVY, FREESTYLE LIBRE 3, Ozempic, QULIPTA, SHINGRIX, UBRELVY, Wegovy, Rybelsus.
Industry payments across NY — which companies pay providers there.
